Recent Articles from GlobeNewswire

New generation of parachute technology combines a completely new design, swappable parachute capsules and triple sensor redundancy to redefine drone safety

NO-HEADQUARTERS/REDWOOD CITY, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- PubMatic, Inc. (Nasdaq: PUBM), an independent technology company delivering digital advertising’s supply chain of the future, today announced that it will release its financial results for the first quarter ended March 31, 2025 after market close on May 8, 2025. On that day, PubMatic will host a webcast at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss the company’s financial results. 

MONTEVIDEO, Uruguay, April 17, 2025 (GLOBE NEWSWIRE) -- DLocal Limited (NASDAQ: DLO, “dLocal” or the “Company”), a technology-first payments platform enabling global enterprise merchants to connect with billions of consumers in emerging markets, intends to release financial results for its first fiscal quarter ended March 31, 2025 on May 14, 2025 after market close.

New offering delivers convenience and benefits to residents while solving compliance and operational challenges for property managers

AUDUBON, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended March 31, 2025 after the market close on Thursday, May 8, 2025. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com.

SAN FRANCISCO, April 17, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the first quarter 2025 after the close of trading on Thursday, May 1, 2025. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET.

WALTHAM, Mass., April 17, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of therapies for autoimmune diseases, today announced that on April 15, 2025 (the “Grant Date”), the Compensation Committee of the Company’s Board of Directors (the “Committee”) granted non-qualified stock options to two newly hired officers of the Company, each as an inducement material to each officer’s entry into employment with the Company, in accordance with Nasdaq Listing Rule 5635(c)(4).

Wade Brings Proven Expertise in AI-Driven Innovation and Scalable Tech-Enabled Growth

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its first quarter 2025 financial results on Thursday, May 8, 2025 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:30 a.m. Eastern Time that day.

Management to discuss first quarter 2025 results and host investor Q&A at virtual event

SBA Reports 74% Increase in 7(a) Loan Volume for Manufacturers Compared to Start of Biden Administration

SAN FRANCISCO, April 17, 2025 (GLOBE NEWSWIRE) -- Allbirds, Inc. (NASDAQ: BIRD), a global lifestyle brand that innovates with sustainable materials to make better products in a better way, today announced that its first quarter 2025 financial results will be released after market close on Thursday, May 8, 2025. The company will host a conference call to discuss the results at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on the same day.

LITTLE ROCK, Ark., April 17, 2025 (GLOBE NEWSWIRE) -- Westrock Coffee Company (NASDAQ: WEST) ("Westrock Coffee" or the “Company") today announced that it will report its first quarter 2025 results on Thursday, May 8, 2025 after market close. The announcement will be followed by a live earnings conference call at 4:30 p.m. ET.

VALENCIA, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound company delivering transformative solutions, today announced that it will report its first quarter 2025 financial results after the close of the U.S. financial markets on Thursday, May 8, 2025. AVITA Medical will host a conference call and webcast that day at 1:30 p.m. Pacific Time (Friday, May 9, 2025, at 6:30 a.m. Australian Eastern Standard Time) to discuss its financial results and recent business highlights.

SCHAUMBURG, Ill., April 17, 2025 (GLOBE NEWSWIRE) -- Paylocity Holding Corporation (Nasdaq: PCTY), a leading provider of cloud-based HR, payroll, and spend management software solutions, today announced that it has scheduled a conference call to review its third quarter fiscal 2025 results for Thursday, May 1st at 4:30 pm Central Time (5:30 pm Eastern Time).

SAN DIEGO, April 17, 2025 (GLOBE NEWSWIRE) -- LPL Financial Holdings Inc. (Nasdaq: LPLA) (the “Company”), the parent corporation of LPL Financial LLC, announced today it will report first quarter financial results after the market closes on Thursday, May 8. The Company will host a conference call to discuss its results at 5 p.m. ET the same day.

Gary Cohn to join the Board as Lead Independent Director

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Nvni Group Limited (Nasdaq: NVNI) (“Nuvini” or the “Company”), a leading acquirer of private SaaS B2B companies in Latin America, has received notice from the listing qualifications department staff of The Nasdaq Stock Market ("Nasdaq") stating that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1 per share, and Listing Rule 5550(b)(2), which requires listed securities to maintain a minimum Market Value of Listed Securities (MVLS) of $35 million.

GREENWICH, Conn., April 17, 2025 (GLOBE NEWSWIRE) -- XPO (NYSE: XPO) will hold its first quarter conference call and webcast on Wednesday, April 30, at 8:30 a.m. Eastern Time. The company's results will be released earlier that morning and made available on www.xpo.com.Access information:Call toll-free from US/Canada: 1-877-269-7756International callers: +1-201-689-7817Live webcast online at: www.xpo.com/investorsA replay of the conference call will be available until May 30, 2025, by calling toll-free (from US/Canada) 1-877-660-6853; international callers dial +1-201-612-7415. Use the passcode 13753296. Additionally, the call will be archived on www.xpo.com/investors.About XPOXPO, Inc. (NYSE: XPO) is a leader in asset-based less-than-truckload (LTL) freight transportation in North America. The company’s customer-focused organization efficiently moves 18 billion pounds of freight per year, enabled by its proprietary technology. XPO serves approximately 55,000 customers with 614 locations and 38,000 employees in North America and Europe, with headquarters in Greenwich, Conn., USA. Visit xpo.com for more information, and connect with XPO on LinkedIn, Facebook, X, Instagram and YouTube.Investor ContactBrian Scasserra+1-617-607-6429brian.scasserra@xpo.comMedia ContactCole Horton+1-203-609-6004cole.horton@xpo.com

MALVERN, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report first quarter 2025 financial results on Thursday, May 8, 2025. TELA Bio’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.

The Daily Wire, The Federalist, State of Texas v. Department of State, et al.

Conference Call to Discuss Results Scheduled for May 8th, 2025

NAARDEN, the Netherlands and MIAMI, April 17, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced the appointment of Adele Gulfo as an independent director to its Board of Directors. Ms. Gulfo is an established pharmaceutical leader with over three decades of experience in the healthcare industry, distinguished by her expertise in global strategy, operations leadership, and the commercialization of multiple blockbuster medicines including LIPITOR® and CRESTOR®.

DENVER, April 17, 2025 (GLOBE NEWSWIRE) -- Psychedelic Science — the premier global gathering for psychedelic research, medicine, policy, and culture hosted by the Multidisciplinary Association for Psychedelic Studies (MAPS) — announces the expansion of its lineup of expert speakers and immersive sessions. On June 16–20, 2025, at the Colorado Convention Center in Denver, Psychedelic Science 2025 (PS2025) will convene thousands of attendees from around the world for five transformative days of education, inspiration, and integration. Registration is now open for community members, practitioners, and businesses to attend the most extraordinary week of the psychedelic movement.

Joveo’s Unified Analytics recognized for enabling talent acquisition leaders to make data-driven recruitment marketing decisions with unmatched clarity and control

LOS ANGELES, April 17, 2025 (GLOBE NEWSWIRE) -- Wonderful® Pistachios will make its triumphant return as the Official Snack sponsor for Combo Breaker 2025, marking its second year at the heralded video game and tournament series. On the heels of its launch, Wonderful Pistachios will serve its new Dill Pickle flavor of No Shells at the event, offering free samples of this dill-iciously bold, tangy and healthy snack option to attendees watching or participating in the action-packed competition.

Ramsey, NJ, April 17, 2025 (GLOBE NEWSWIRE) -- Konica Minolta Business Solutions U.S.A., Inc. (Konica Minolta) today announced the official launch of Blue Iris IQ, a dynamic new division leveraging the foundation of the company’s existing Intelligent Information Management (IIM) services. With a logic-driven, customer-centric approach, Blue Iris IQ delivers tailored solutions designed to streamline data complexity and provide an automated approach to business operations. Its AI-powered offerings have the strength and ability to uncover deeper insights and predictive value from enterprise content, while its scalable solutions are designed to grow alongside any organization’s digital transformation journey.

TORONTO, April 17, 2025 (GLOBE NEWSWIRE) -- Inventus Mining Corp. (TSXV: IVS) (“Inventus” or the “Company”) is pleased to announce that the Company will make an application to the TSX Venture Exchange (the “TSXV”) for approval of the implementation of an early warrant exercise incentive program (the “Program”) designed to encourage the early exercise of up to 15,000,000 outstanding common share purchase warrants (the “Eligible Warrants”) originally issued in connection with the Company’s private placement financing that closed on November 6th, 2024. Each Eligible Warrant entitles the holder to purchase one common share of the Company at a price of $0.09 per share and expires on November 6th, 2026.

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Movado Group, Inc. (“Movado” or the “Company”) (NYSE: MOV).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.   

WARREN, N.J., April 17, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced it has entered into an agreement with CD 8 Technology Services LLC (“CD8”) for the development and/or acquisition of a turn-key facility that is intended to support both in-house pre-clinical research and GMP cell therapy production capabilities.

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Kyndryl Holdings, Inc. (“Kyndryl” or the “Company”) (NYSE: KD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.   

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Treace Medical Concepts, Inc. (“Treace Medical” or the “Company”) (NASDAQ: TMCI).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.   

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Flywire Corporation (“Flywire” or the “Company”) (NASDAQ: FLYW).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Valneva SE (“Valneva” or the “Company”) (NASDAQ: VALN).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Ibotta, Inc. (“Ibotta” or the “Company”) (NYSE: IBTA).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Biohaven Ltd. (“Biohaven” or the “Company”) (NYSE: BHVN).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of CarMax, Inc. (“CarMax” or the “Company”) (NYSE: KMX).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.   

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Methanex Corporation (“Methanex” or the “Company”) (NASDAQ: MEOH).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Teleflex Incorporated (“Teleflex” or the “Company”) (NYSE: TFX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Company Celebrates Transition to a Public Company; Shares Trade Under “CHA” Ticker

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  PepGen Inc. (“PepGen” or the “Company”) (NASDAQ: PEPG).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Pliant Therapeutics, Inc (“Pliant” or the “Company”) (NASDAQ: PLRX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Profound Medical Corp. (“Profound” or the “Company”) (NASDAQ: PROF). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Fortrea Holdings Inc. (“Fortrea” or the “Company”) (NASDAQ: FTRE).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

RENO, Nev., April 17, 2025 (GLOBE NEWSWIRE) -- ITS Logistics today released the Q2 ITS Logistics US Distribution and Fulfillment Index, Powered by Cresa. This quarter, the index reveals some conflicting outlooks across the industry, underscoring current global supply chain uncertainty.

ALEXANDRIA, Va., April 17, 2025 (GLOBE NEWSWIRE) -- DCS Corporation is pleased to announce the appointment of Tanya Bassett to Vice President of Business Development. In this role, Tanya will lead the company’s strategic business development and new market infiltration efforts.

ATLANTA, April 17, 2025 (GLOBE NEWSWIRE) -- Gray Media has promoted Dana Neves to Senior Managing Vice President, effective immediately. In her new role, Dana oversees a number of Gray’s television markets in the Northeast and Mid-Atlantic areas. For the past 7 years, Dana has served as the General Manager of Gray’s WFSB (CBS) in Hartford, Connecticut, and has led its Connecticut-focused broadcast sports network The Wax since its launch last year.   Gray will soon begin a search for Dana’s successor.

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Horizon Technology Finance Corporation (“Horizon” or the “Company”) (NASDAQ: HRZN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Gorilla Technology Group, Inc. (“Gorilla” or the “Company”) (NASDAQ: GRRR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of NET Power Inc. (“Net Power” or the “Company”) (NYSE: NPWR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of RH (“RH” or the “Company”) (NYSE: RH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Robinhood Markets, Inc. (“Robinhood” or the “Company”) (NASDAQ: HOOD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Daktronics, Inc. (“Daktronics” or the “Company”) (NASDAQ: DAKT).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Xponential Fitness, Inc. (“Xponential” or the “Company”) (NYSE: XPOF).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  XP Inc. (“XP” or the “Company”) (NASDAQ: XP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Oceana analysis shows long-lasting harms of worst oil spill in U.S. history

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  HealthEquity, Inc (“HealthEquity” or the “Company”) (NASDAQ: HQY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Allbirds, Inc. (“Allbirds” or the “Company”) (NASDAQ: BIRD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  OSI Systems, Inc. (“OSI” or the “Company”) (NASDAQ: OSIS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  iRobot Corporation (“iRobot” or the “Company”) (NASDAQ: IRBT).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  RLX Technology Inc. (“RLX” or the “Company”) (NYSE: RLX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Transaction in Own Shares

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Sarepta Therapeutics, Inc. (“Sarepta” or the “Company”) (NASDAQ: SRPT).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Affirm Holdings, Inc. (“Affirm” or the “Company”) (NASDAQ: AFRM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

As mainstream adoption of major cryptocurrencies like BTC, LTC, and DOGE continues to grow, so does the demand for mining these digital assets. While traditional mining attracted many investors over the past decade, the increasing difficulty levels and soaring electricity costs have priced out most individuals.

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Bitfarms Ltd. (“Bitfarms” or the “Company”) (NASDAQ: BITF). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Nyxoah S.A. (“Nyxoah” or the “Company”) (NASDAQ: NYXH).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  KinderCare Learning Companies, Inc. (“KinderCare” or the “Company”) (NYSE: KLC).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

STAMFORD, Conn., April 17, 2025 (GLOBE NEWSWIRE) -- KAYAK, the world’s leading travel search engine, launches its Spring Savings Travel Hacker Report, dishing out expert tips to score the best deals this Spring. Nearly 78% of Americans cite cost as a consideration for their travel frequency, with airfare costs (50%) topping their concerns. This underscores the increasing importance of savings.

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Pony AI Inc. (“Pony” or the “Company”) (NASDAQ: PONY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  The Vita Coco Company, Inc. (“Vita Coco” or the “Company”) (NASDAQ: COCO).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of 3D Systems Corporation (“3D Systems” or the “Company”) (NYSE: DDD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

SPRING 2025 MEMORABILIA ONLINE AUCTION OPEN FROM 21 APRIL - 4 MAY WITH OVER 130 LOTS

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Endeavour Silver Corp. (“Endeavour” or the “Company”) (NYSE: EXK).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

17 April 2025, 19:00 CET